Diagnostics
The power and limits of zeroing in
The power and limits of zeroing in
A health-care revolution in the making
A sampler of diagnostics emerging from Stanford
Doubts mount over move to end off-label drug oversight
New drug approvals ebb; doubts over testing's gold standard grow
The human subjects trade is booming, largely without oversight
Serving in clinical trials offers lessons for living
Why nothing really is something, and in some ways is better than anything
Musings on why evidence can persuade, but a good story compels
Minds of all kinds join to hasten discoveries of new medical treatments